Concepedia

Sylvia A. Holden

SA

Statistics

Publications

65

Citations

5.2K

H-Index

32

Active since

1985

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Harvard University Press

Sylvia A. Holden is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacology, and oncology.

Top concepts

Publications per year

1985–2001

65

Publications

65

Differentiation and reversal of malignant changes in colon cancer through PPARγ

Pasha Sarraf, Elisabetta Mueller, Daniel M. Jones et al. · Nature Medicine · 1998 · 969 citations

, , +9

Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

Tetsuya Kubota, Kozo Koshizuka, Elizabeth A. Williamson et al. · PubMed · 1998 · 588 citations

, , +13

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

Beverly A. Teicher, Terence S. Herman, Sylvia A. Holden et al. · Science · 1990 · 316 citations

, , +13

Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).

Beverly A. Teicher, Sylvia A. Holden, Michael J. Kelley et al. · PubMed · 1987 · 291 citations

, , +17

Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents

Beverly A. Teicher, Sylvia A. Holden, Gulshan Ara et al. · International Journal of Cancer · 1994 · 233 citations

1–5 of 65